|

Adoptive therapy with autologous MC2 TCR T cells Clinical Trials

1 actively recruiting trial

Also known as: 5' Azacytidine (AZA), Interleukin 2 (IL2), Valproic acid (VP)

Pipeline

Phase 1/2: 1

Top Sponsors

  • Erasmus Medical Center1

Indications

  • Melanoma, Uveal1
  • Melanoma1
  • Head and Neck Cancer1
  • Cancer1

Other1 trial

MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.